The overall objective is to elucidate the molecular basis of the inherited metabolic disorders of fatty acid metabolism due to a deficiency of short- (SCAD), medium- (MCAD) and long chain acyl-CoA dehydrogenases (LCAD). These disorders are important in the differential diagnosis of children with episodic acidosis, hypoglycemia or myopathy. SCAD, MCAD, and LCAD catalyze the first reaction of the Beta oxidation cycles in the fatty acid catabolism. They are all mitochondrial flavoenzymes. These three enzymes and two other acyl-CoA dehydrogenases, that are involved in the branched chain amino acid metabolism, share many similarities in the molecular weight, subunit structure, active site, and reaction mechanisms. They differ in the length and steric configuration of the acyl-CoA substrate, however. These considerations led us to hypothesize that these enzymes belong to a family (the acyl-CoA dehydrogenase family) and share a common ancestor, but acquired distinctive structural diversity and substrate specificity in the course of evolution. This hypothesis must be tested, however, by the determination of nucleotide sequences of cDNA's. Individual experiments proposed are: 1) purification and characterization of human SCAD, MCAD and LCAD; 2) study of residual activities in the cells from patients with a deficiency of SCAD or MCAD; 3) biosynthesis of variant SCAD and LCAD in cultured fibroblasts from patients with a deficiency of the respective enzyme; 4) amino acid sequencing of the peptide containing the essential cysteine residue that is located in the active site, and other tryptic peptides; 5) molecular cloning of cDNA's encoding SCAD, MCAD, and LCAD; 6) chromosome mapping of SCAD, MCAD, and LCAD; 7) large scale preparation of MCAD using cloned cDNA and an expression vector for the study of the three dimensional structures by X-ray crystallography 8) study of single base substitution(s) in variant MCAD using ribonuclease A; 9) identification of point mutation in variant MCAD gene; and 10) molecular study of mutant human SCAD and LCAD genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038154-04
Application #
3237392
Study Section
Biochemistry Study Section (BIO)
Project Start
1987-01-01
Project End
1991-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Saijo, T; Kim, J J; Kuroda, Y et al. (1998) The roles of threonine-136 and glutamate-137 of human medium chain acyl-CoA dehydrogenase in FAD binding and peptide folding using site-directed mutagenesis: creation of an FAD-dependent mutant, T136D. Arch Biochem Biophys 358:49-57
Tanaka, K; Gregersen, N; Ribes, A et al. (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutiona Pediatr Res 41:201-9
Saijo, T; Tanaka, K (1995) Isoalloxazine ring of FAD is required for the formation of the core in the Hsp60-assisted folding of medium chain acyl-CoA dehydrogenase subunit into the assembly competent conformation in mitochondria. J Biol Chem 270:1899-907
Saijo, T; Welch, W J; Tanaka, K (1994) Intramitochondrial folding and assembly of medium-chain acyl-CoA dehydrogenase (MCAD). Demonstration of impaired transfer of K304E-variant MCAD from its complex with hsp60 to the native tetramer. J Biol Chem 269:4401-8
Yamaguchi, S; Indo, Y; Coates, P M et al. (1993) Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 34:111-3
Nagao, M; Raymond, D; Kim, J et al. (1993) Improved PCR/NcoI method for the molecular diagnosis of medium chain acyl-CoA dehydrogenase deficiency using dried blood samples: two-stage amplification using two different sets of primers improves accuracy and sensitivity. Clin Chim Acta 220:165-74
Parimoo, B; Tanaka, K (1993) Structural organization of the human isovaleryl-CoA dehydrogenase gene. Genomics 15:582-90
Nagao, M; Parimoo, B; Tanaka, K (1993) Developmental, nutritional, and hormonal regulation of tissue-specific expression of the genes encoding various acyl-CoA dehydrogenases and alpha-subunit of electron transfer flavoprotein in rat. J Biol Chem 268:24114-24
Yokota, I; Saijo, T; Vockley, J et al. (1992) Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein. J Biol Chem 267:26004-10
Coates, P M; Indo, Y; Young, D et al. (1992) Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 31:34-8

Showing the most recent 10 out of 24 publications